Merck(MRK) said Friday that it has hired Peter Kellogg of Biogen Idec(BIIB) as its new chief financial officer.
Kellogg, who has been the biotech company's CFO since 2004, replaces Judy Lewent, who said in February that she would retire by mid-year. Kellogg will leave Biogen Idec on Aug. 10 and join Merck on Aug. 14. Biogen Idec said it would announce its plans for a successor in a few weeks. Merck is the second Big Pharma company to announce a change in CFOs in the last 24 hours. On Thursday, Wyeth(WYE) promoted Greg Norden, an 18-year veteran, to succeed Kenneth Martin, who is retiring June 30. "We conducted a comprehensive search for the right person and considered a number of excellent candidates both inside and outside of Merck," said Richard Clark, Merck's chairman and CEO, in announcing Kellogg's appointment. Previously, Kellogg had been CFO at Biogen, which merged with Idec Pharmaceuticals in 2003. Kellogg also held several financial and management jobs at PepsiCo(PEP) and was a senior partner at two consulting firms, Booz Allen & Hamilton and Arthur Andersen.>To order reprints of this article, click here: ReprintsTheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,890.46 | 1,351.95 | 2,927.23 | 20.47 |
Oil *
118.75
|
|
UP
6.51 |
UP
1.99 |
UP
11.37 |
UP
0.72 |
10 Yr
2.05%
SPDR Gold
168.02
|
|
+0.05%
|
+0.15%
|
+0.39%
|
+3.65%
|
Data delayed 20 minutes |
Connect with TheStreet